Li X - Search Results

1

Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study.

Feng K, Liu Y, Zhao Y, Yang Q, Dong L, Liu J, Li X, Zhao Z, Mei Q, Han W. Feng K, et al. Among authors: li x. J Immunother Cancer. 2020 Jun;8(1):e000367. doi: 10.1136/jitc-2019-000367. J Immunother Cancer. 2020. PMID: 32487569 Free PMC article. Clinical Trial.

2

A facile and specific assay for quantifying microRNA by an optimized RT-qPCR approach.

Mei Q, Li X, Meng Y, Wu Z, Guo M, Zhao Y, Fu X, Han W. Mei Q, et al. Among authors: li x. PLoS One. 2012;7(10):e46890. doi: 10.1371/journal.pone.0046890. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071657 Free PMC article.

3

Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes.

Li X, Zhang Y, Zhao L, Wang L, Wu Z, Mei Q, Nie J, Li X, Li Y, Fu X, Wang X, Meng Y, Han W. Li X, et al. Among authors: li y. Hum Mol Genet. 2014 Nov 15;23(22):6008-21. doi: 10.1093/hmg/ddu330. Epub 2014 Jun 26. Hum Mol Genet. 2014. PMID: 24969084

4

Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors.

Nie J, Liu L, Li X, Han W. Nie J, et al. Among authors: li x. Cancer Lett. 2014 Nov 1;354(1):12-20. doi: 10.1016/j.canlet.2014.08.010. Epub 2014 Aug 14. Cancer Lett. 2014. PMID: 25130173 Review.

5

The miRNA network: micro-regulator of cell signaling in cancer.

Mei Q, Li X, Guo M, Fu X, Han W. Mei Q, et al. Among authors: li x. Expert Rev Anticancer Ther. 2014 Dec;14(12):1515-27. doi: 10.1586/14737140.2014.953935. Epub 2014 Aug 28. Expert Rev Anticancer Ther. 2014. PMID: 25163801 Review.

6

The four-herb Chinese medicine ANBP enhances wound healing and inhibits scar formation via bidirectional regulation of transformation growth factor pathway.

Hou Q, He WJ, Hao HJ, Han QW, Chen L, Dong L, Liu JJ, Li X, Zhang YJ, Ma YZ, Han WD, Fu XB. Hou Q, et al. Among authors: li x. PLoS One. 2014 Dec 9;9(12):e112274. doi: 10.1371/journal.pone.0112274. eCollection 2014. PLoS One. 2014. PMID: 25489732 Free PMC article.

7

Decitabine: a promising epi-immunotherapeutic agent in solid tumors.

Li X, Mei Q, Nie J, Fu X, Han W. Li X, et al. Expert Rev Clin Immunol. 2015 Mar;11(3):363-75. doi: 10.1586/1744666X.2015.1002397. Epub 2015 Jan 12. Expert Rev Clin Immunol. 2015. PMID: 25578329 Review.

8

Methylation-induced loss of miR-484 in microsatellite-unstable colorectal cancer promotes both viability and IL-8 production via CD137L.

Mei Q, Xue G, Li X, Wu Z, Li X, Yan H, Guo M, Sun S, Han W. Mei Q, et al. Among authors: li x. J Pathol. 2015 Jun;236(2):165-74. doi: 10.1002/path.4525. Epub 2015 Apr 21. J Pathol. 2015. PMID: 25727216

9

An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks.

Wu Z, Wang C, Bai M, Li X, Mei Q, Li X, Wang Y, Fu X, Luo G, Han W. Wu Z, et al. Among authors: li x. Nucleic Acids Res. 2015 Mar 31;43(6):3167-79. doi: 10.1093/nar/gkv161. Epub 2015 Mar 3. Nucleic Acids Res. 2015. PMID: 25735744 Free PMC article.

10

An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma.

Mei Q, Chen M, Lu X, Li X, Duan F, Wang M, Luo G, Han W. Mei Q, et al. Among authors: li x. Oncotarget. 2015 Jun 30;6(18):16698-711. doi: 10.18632/oncotarget.3677. Oncotarget. 2015. PMID: 25895027 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183,004 results

Search Page

Filters